Jacob Tolstrup
Chairman presso Lundbeck Pharma A/S
Profilo
Jacob Tolstrup is currently the Chairman at Pharmacosmos A since 2019 and the Chairman at Lundbeck Pharma A since 2017.
He is also a Director at Antoax A.
Previously, he served as the Vice President-Finance & Administration at Lundbeck Research USA, Inc. from 2010 to 2012 and as the Chief Commercial Officer at H.
Lundbeck A from 2022 to 2024.
Mr. Tolstrup holds a graduate degree from the University of Aalborg and an MBA from Munich Business School.
Posizioni attive di Jacob Tolstrup
| Società | Posizione | Inizio |
|---|---|---|
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Chairman | 14/11/2017 |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Chairman | 01/02/2019 |
Antoax A/S
 Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Director/Board Member | - |
Precedenti posizioni note di Jacob Tolstrup
| Società | Posizione | Fine |
|---|---|---|
| H. LUNDBECK A/S | Human Resources Officer | 31/12/2015 |
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Director of Finance/CFO | 01/01/2012 |
Formazione di Jacob Tolstrup
| University of Aalborg | Graduate Degree |
| Munich Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| Aziende private | 4 |
|---|---|
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Health Technology |
Antoax A/S
Antoax A/S Financial ConglomeratesFinance Antoax A/S is an investment holding Danish company. The company is based in Holbæk, DK and has subsidiaries in the United States, Denmark, and the United Kingdom. The company was founded in 2004. The CEO is Robert Guglielmetti. | Finance |
Lundbeck Pharma A/S
Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Distribution Services |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Jacob Tolstrup
